These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3116959)
41. [Therapy of reflux esophagitis. Manometric determination of the effect of bromoprid on the lower esophageal sphincter]. Mantelmacher H; Bettarello A Fortschr Med; 1978 Nov; 96(41):2117-20. PubMed ID: 700599 [TBL] [Abstract][Full Text] [Related]
43. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials. Koelz HR Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015 [TBL] [Abstract][Full Text] [Related]
44. Effects of long-term medical treatment with cimetidine and bethanechol in patients with esophagitis and Barrett's esophagus. Humphries TJ J Clin Gastroenterol; 1987 Feb; 9(1):28-32. PubMed ID: 2881958 [TBL] [Abstract][Full Text] [Related]
45. A controlled trial of metoclopramide in symptomatic gastroesophageal reflux. McCallum RW; Ippoliti AF; Cooney C; Sturdevant RA N Engl J Med; 1977 Feb; 296(7):354-7. PubMed ID: 319356 [TBL] [Abstract][Full Text] [Related]
46. Future medical therapy of reflux esophagitis. Castell DO J Clin Gastroenterol; 1986; 8 Suppl 1():81-5. PubMed ID: 2874169 [TBL] [Abstract][Full Text] [Related]
49. [Erosive reflux-esophagitis and its treatment]. Geller LI; Bessonova GA; Petrenko VF Ter Arkh; 1991; 63(1):81-4. PubMed ID: 2057905 [TBL] [Abstract][Full Text] [Related]
50. Combination therapy of sucralfate and cimetidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis. Schotborgh RH; Hameeteman W; Dekker W; vd Boomgaard DM; Van Olffen GH; Schrijver M; Vosmaer GD; Tytgat GN Am J Med; 1989 Jun; 86(6A):77-80. PubMed ID: 2660561 [TBL] [Abstract][Full Text] [Related]
51. Effect of a new H2-blocker, famotidine, in reflux esophagitis among severely handicapped children. Miyake S; Yamada M; Iwamoto H; Yamashita S; Sugio Y Clin Ther; 1987; 9(5):548-58. PubMed ID: 2889529 [TBL] [Abstract][Full Text] [Related]
52. Lack of effect of metoclopramide and domperidone on esophageal peristalsis and esophageal acid clearance in reflux esophagitis. A randomized, double-blind study. Grande L; Lacima G; Ros E; GarcĂa-Valdecasas JC; Fuster J; Visa J; Pera C Dig Dis Sci; 1992 Apr; 37(4):583-8. PubMed ID: 1551349 [TBL] [Abstract][Full Text] [Related]
53. Efficacy of sucralfate in refractory reflux esophagitis. Results of a pilot study. Ros E; Pujol A; Bordas JM; Grande L Scand J Gastroenterol Suppl; 1989; 156():49-55. PubMed ID: 2740842 [TBL] [Abstract][Full Text] [Related]
54. Bethanechol or cimetidine in the treatment of symptomatic reflux esophagitis: a double-blind control study. Thanik K; Chey WY; Shak A; Hamilton D; Nadelson N Arch Intern Med; 1982 Aug; 142(8):1479-81. PubMed ID: 6125135 [TBL] [Abstract][Full Text] [Related]
55. 24-hour esophageal pH monitoring before and after medical therapy for reflux esophagitis. Lieberman DA Dig Dis Sci; 1988 Feb; 33(2):166-71. PubMed ID: 3338365 [TBL] [Abstract][Full Text] [Related]
56. The effect of oral and intravenous metoclopramide on human lower esophageal sphincter pressure. Cohen S; Morris DW; Schoen HJ; DiMarino AJ Gastroenterology; 1976 Apr; 70(4):484-7. PubMed ID: 767194 [TBL] [Abstract][Full Text] [Related]